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Abstract
Background: Lymphocyte function-associated antigen-1 (LFA-1, CD11a/CD18, alpha L beta 2) is
required for many cellular adhesive interactions during the immune response.
Results: The Capra hircus CD11a-encoding cDNA was sequenced and compared with its human,
murine, rat, bovine and ovine counterparts. Despite some focal differences, it shares all the main
characteristics of its known mammalian homologues.
Conclusion: Therefore, along with the caprine CD18-encoding cDNA, which has been available
for a few months, the sequence data revealed here will allow the Capra hircus LFA-1 expression in
vitro as a tool to explore the specificities of inflammation in the caprine species.
Background
Lymphocyte function-associated antigen-1 (LFA-1, αLβ2,
CD11a/CD18) is a member of the β2-integrin subfamily
of cell surface receptors. Integrins consist of a 120 to 180
kDa α subunit (CD11a in this case) and a 90 to 110 kDa
β subunit that are noncovalently associated single-pass
transmembrane proteins [1]. The bulk of each integrin
subunit is extracellular, where it typically functions as a
receptor for extracellular matrix molecules or as a counter-
receptor for surface proteins of apposed cells [2]. The het-
erodimer CD11a/CD18 is expressed on all leukocytes and
mediates high affinity adhesion to a variety of cell types
that express one or more of the β2-integrins ligands, inter-
cellular adhesion molecules (ICAM-1 to -5) [3-5]. The
adhesion process mediated is a critical step of a wide range
of immunological activities, including cytolysis of target
cells, cross-interaction and cross-stimulation between
lymphocytes, phagocytosis of complement-coated targets,
neutrophils clearance from inflamed tissue, and the regu-
lation of leukocyte traffic between the bloodstream and
tissues [6-9]. As the relevance of the goat model for stud-
ying leukocyte traffic, diapedesis and pathologic tissue
infiltration is well established in such important areas as
mastitis [10-13] or lentivirus-associated diseases [14-16],
increasing our knowledge about caprine β2 integrins is of
great importance to offer new possibilities for research
and to provide additional insights into those fields. Along
with the caprine CD18-encoding cDNA, which is availa-
ble for a few months [17], the sequence data provided
here will allow the Capra hircus β2-integrin CD11a/CD18
expression in vitro as a tool to examine the specificities of
inflammation in the caprine species.
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RNA isolation
Total RNA from phorbol myristate acetate (PMA)-stimu-
lated (25 ng/ml for 15 min) caprine (Boer breed) periph-
eral blood mononuclear cells (PBMC) was extracted with
TRIzol (Invitrogen, USA) as described by the manufac-
turer. The PBMCs were obtained by density gradient cen-
trifugation with Ficoll-Paque Plus (Amersham, USA) and
maintained in RPMI 1640 supplemented with 10% foetal
bovine serum (Gibco BRL, USA), penicillin (100 U/ml)
and streptomycin (100 µg/ml) at 37°C in a 5% CO2
atmosphere.
Amplification of cDNA ends
We used SMART RACE technology (Clontech Laboratories
Inc., USA) to obtain caprine CD11a (CaCD11a) 5'- and 3'-
ends and RT-PCR to amplify full-length CaCD11a CDS.
For first-strand cDNA synthesis, and according to the
sequence of bovine CD11a available [GenBank:
AY267467], gene-specific primers were designed which
were expected to give non overlapping ~1 kb RACE prod-
ucts: a sense primer for the 3'-RACE PCR : 5'-TGCAAT-
GTRAGCTCTCCCATCTTC-3' (corresponding to nt 2572
to nt 2595) and an antisense primer for the 5'-RACE PCR
: 5'-CCGGCCTCCTCTCTGCTCCCCATAG-3' (nt 1470 to
nt 1446). Reverse transcription and polymerase chain
reactions (PCR) were carried out according to the instruc-
tion manual of the SMART RACE cDNA Amplification Kit.
The 5'- and 3'-RACE products were gel-purified using the
S.N.A.P.™ Gel Purification Kit (Invitrogen, USA), TA-
cloned into pCRII-TOPO (Invitrogen, USA) and seeded
on kanamycin IPTG plates. Miniprep were obtained from
colonies grown in 5 ml LB-kanamycin broth and the
clones were sequenced on the ABI-3730 Genetic Analyzer
using the Big Dye terminator chemistry (Applied Biosys-
tems, USA).
Molecular cloning of full-length cDNA
Total RNA from PMA-stimulated PBMCs was reverse tran-
scribed using Improm II (Promega, USA). The full-length
cDNA was then generated by long distance PCR using
Platinum Taq DNA polymerase High Fidelity (Invitrogen,
USA) with primers designed from the distal ends of both
5'- and 3'-RACE products : 5'-GTCGCCAGTAAATC-
CCAAGA-3' (sense, within the 5'-UTR) and 5'-GCACCT-
CAATCTCCACCACT-3' (antisense, 3'UTR). The
procedures recommended by the manufacturer were fol-
lowed, with these cycling parameters : 5 min at 94°C, then
35 cycles including (i) 30 s at 94°C, (ii) 30 s at 58°C and
(iii) 3 min 30 s at 68°C, followed by a final extension at
68°C for 5 min. Resulting PCR products were then proc-
essed for sequencing as aforementioned for the RACE
products. The CD11a cDNA sequence was deduced from
sequences obtained from nine independent clones.
Sequence data have been deposited at GenBank under
accession No. AY773018 and AY773019.
Bioinformatics
Primers design was performed with Netprimer [18] and
Primer 3 [19]. Nucleotidic sequence and similarity analy-
ses were carried out using respectively Chromas v.2.21
[20] and BLAST programs [21]. Alignment of amino acids
sequences were drawn by GeneDoc v.2.6.002 [22] follow-
ing the BLOSUM62 matrix. SignalP v.2.0.b2 [23] and
NetNGlyc v.1.0 [24] provided peptide signal and N-glyco-
sylation sites prediction, respectively.
Results & discussion
Characterisation of CaCD11a-encoding cDNA and 
deduced aa sequence
Two alleles have been identified for the CaCD11a cDNA.
The sequence contains ~4200 bp with an ORF of 3498
[Genbank: AY773019] or 3495 bp [Genbank: AY773018]
depending on the allele that codes for 1165 or 1164 aa
followed by ~600 bp in the 3'-UTR (Fig. 1). The mature
CaCD11a contains a 23-aa putative leader peptide, an
extracellular domain of 1061 or 1062 residues (24-1084/
1085), a single hydrophobic transmembrane region of 24
residues (1085/1086–1108/1109) and a cytoplasmic tail
of 57 residues (Fig. 1). Nine N-linked putative glycosyla-
tion sites (Asn-X-Thr/Ser) are present in the extracellular
domain (Fig. 2). The mature protein contains 19 cysteine
residues among which one is located into the cytoplasmic
tail (Fig. 2). The extracellular domain also contains an
inserted (I) domain of 172 amino acids (residues 153–
324) quite similar to those found in all the leukocyte
integrin α subunits sequenced to date and located
between the β sheets 2 and 3 of a seven bladed β-propeller
region [25]. The I-domain is homologous with repeated
domains found in von Willebrand factor and cartilage
matrix protein [1] and can be expressed as an isolated
domain. Its three-dimensional structure consists of a five-
stranded parallel β-sheet core surrounded on both faces
by α-helices, with a short antiparallel strand occurring on
one edge of this sheet [26]. The I-domain contains a metal
ion-dependent adhesion site (MIDAS) [27] (residues
159–163, 228, 261) (Fig. 2) and an I-domain allosteric
site (IDAS) that plays a functional role in ICAM-1 binding
[28-30]. Three repeats with a divalent cation binding
motif are found at amino acid residues 465–473, 527–
535 and 587–595 (Fig. 2). All the conserved cysteines and
all but one N-glycosylation sites are found outside the I
region and divalent cation binding motifs (Fig. 2), con-
sistent with the hypothesis that these regions may
undergo conformational changes important in ligand
binding [31,32].Page 2 of 6
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Overall, the general organization of caprine, bovine [33],
ovine [34], human [32], murine [35] and rat [GenBank:
NW_047562] CD11a proteins is quite similar (Fig. 2).
Comparison between mature CaCD11a sequence and its
bovine, ovine, human, murine and rat counterparts shows
overall 94%, 98%, 77%, 68% and 55% identity, respec-
tively, with the highest identity for the MIDAS, the cation
binding motifs and the transmembrane region and the
lowest identity for the cytoplasmic tail (Table 1). The high
conservation of the MIDAS and the putative cation bind-
ing motifs is consistent with an involvement of these
regions in the functional activity of LFA-1 α subunit, as
suggested by the requirement of Mg2+ and Ca2+ for
CD11a/CD18-dependent cellular interactions [31] or
binding to purified ICAM-1 [36,37]. The transmembrane
region shows also a high degree of conservation that could
be explained by (i) physicochemical, and (ii) functional
constraints. Indeed, (i) residues lying in the membrane
have to possess rather hydrophobic character to allow
liposolubility, which is confirmed by the presence of
many leucine residues (figure 2) and (ii) bi-directional
integrin signalling (inside-out and outside-in) is accom-
plished by transmission of information across the plasma
membrane [38]. By contrast, the low conservation of the
cytoplasmic tail suggests that it is not required to guaran-
tee adequate functioning of LFA-1. This is in agreement
with the observation that truncation of the LFA-1 α subu-
nit cytoplasmic domain has no effect on binding to ICAM-
1, whereas binding is markedly diminished by β subunit
cytoplasmic domain truncation [39]. Residue Glu-332
that is located in the linker following the I-domain and
that is known to be critical for communication to the β2 I-
like domain, rolling, integrin extension and activation by
Mn2+ of firm adhesion [8] is strictly conserved.
Every cysteine residue in the caprine extracellular portion
of mature CD11a is present at the same location in
bovine, ovine, human, murine and rat CD11a, which is
consistent with a role in maintaining the global structure
of the protein whereas two cysteine residues (positions
1009 and 1048) are absent from caprine CD11a and
therefore do not seem to be indispensable. The mouse
version distinguishes by an additional cysteine residue at
The nucleotide and deduced amino acid sequences of Capra hircus CD11a cDNAFigure 1
The nucleotide and deduced amino acid sequences of Capra hircus CD11a cDNA. The putative leader peptide and 
transmembrane region are underlined. Nine independent clones were sequenced in both directions. Sequence data have been 
deposited at GenBank under accession No. AY773018 and AY773019 (shown here), respectively without and with Gln-743 
(#).
1: M N S C T I V M R F L L S G P F V F A P A W S Y N L D V 28
-68: GTCGCCAGTAAATCCCAAGAGCCCTCTGAGGCTATACCTGGGGTGGCTCCCTCCAGCCGGCTTGAAAGATGAATTCCTGCACCATCGTGATGAGGTTCCTGCTGTCTGGGCCTTTTGTCTTTGCCCCAGCCTGGAGCTACAACCTGGATG 82
29: R H V Q N F S F P L A G R H F G Y R V L Q V G N R V V V G A P N E G N R M G N L Y Q C Q P E T G D C 78
83: TGCGACATGTACAAAACTTCTCCTTCCCACTTGCCGGGAGGCATTTTGGGTACCGTGTTCTGCAAGTGGGAAACAGGGTTGTTGTGGGAGCTCCAAATGAAGGGAACAGGATGGGAAACCTGTATCAGTGCCAGCCAGAAACTGGAGACT 232
79: L P V T L S S S Y T S K Y L G M T L A T D P T S G N L L A C D P G L S R T C D Q N I Y L S G L C Y L 128
233: GCCTGCCAGTCACACTGAGTTCCAGCTATACCTCCAAGTACTTGGGAATGACCCTGGCAACAGACCCCACAAGTGGCAACCTTTTGGCCTGTGATCCTGGGCTGTCTCGAACATGTGACCAGAACATCTATCTAAGTGGTCTCTGTTACC 382
129: I H E N L R G P V L Q G H P G Y Q E C I K G N V D L V F L F D G S M S L Q Q D E F G K I V D F M K D 178
383: TCATCCATGAGAATCTGAGGGGTCCCGTGCTACAAGGGCACCCTGGTTATCAGGAATGTATAAAGGGCAACGTAGACTTGGTATTTCTGTTTGATGGCTCAATGAGCTTGCAGCAAGATGAATTTGGGAAAATTGTGGACTTCATGAAGG 532
179: V M K K L S N S S Y Q F A A V Q F S T D F K T E F T F L D Y N R Q K D P D A L L A G V K H M R L L T 228
533: ATGTGATGAAGAAACTCAGCAACTCTTCCTACCAGTTTGCGGCTGTTCAGTTTTCTACAGATTTCAAAACAGAATTTACTTTCTTGGATTACAATAGACAGAAGGACCCTGACGCTCTGTTGGCTGGAGTCAAACACATGCGTTTGTTGA 682
229: N T F G A I N Y V A K E V F R Q E L G A R P D A T K V L I I I T D G E A T D E Q N I D A A K D I I R 278
683: CCAACACCTTTGGTGCCATCAACTATGTTGCGAAAGAAGTGTTCCGGCAAGAGCTGGGAGCCCGCCCAGATGCCACCAAAGTGCTTATCATCATCACTGATGGGGAAGCCACCGACGAACAGAACATTGATGCGGCCAAAGACATTATCC 832
279: Y I I G I G K N F K T K E S Q E A L H Q F A S K P V E E F V K I L D T F E K L K D L F T E L Q K K I 328
833: GCTACATCATTGGGATTGGAAAGAACTTTAAGACCAAAGAAAGTCAGGAGGCGCTCCATCAGTTTGCCTCCAAACCCGTGGAGGAGTTTGTAAAGATCCTGGACACATTTGAGAAGCTGAAAGATCTATTCACCGAGCTGCAGAAAAAGA 982
329: Y V I E G T S K Q D L T S F N M E L S S S G I S A D L S E G H G V V G A V G A K D W A G G F L D L K 378
983: TCTATGTTATTGAGGGCACAAGCAAACAGGACCTGACATCCTTCAACATGGAGCTGTCCTCCAGCGGAATTAGCGCAGACCTCAGCGAGGGCCATGGTGTTGTGGGGGCCGTTGGAGCCAAAGACTGGGCTGGGGGCTTTCTCGACCTGA 1132
379: A D L Q S S T F V G N E Q L T V E S R E G Y L G Y T V T W L P S R G T M S L L A T G A P R Y Q H V G 428
1133: AGGCAGACCTGCAGAGCAGCACATTTGTTGGGAATGAACAACTGACAGTAGAATCGAGGGAAGGATATTTGGGTTACACGGTGACCTGGCTGCCCTCCCGAGGGACCATGTCATTGCTGGCCACTGGAGCCCCCAGATACCAGCATGTCG 1282
429: R V L L F Q Q P K R G G P W S Q I Q K I D G I Q V G S Y F G G E L C G V D V D R D G E T E L L L I A 478
1283: GGCGGGTGCTGCTGTTCCAACAGCCAAAGAGAGGAGGACCCTGGAGCCAGATCCAGAAAATAGATGGGATCCAGGTTGGCTCTTATTTTGGTGGCGAGTTGTGTGGCGTTGACGTGGACAGAGATGGGGAGACAGAGCTGTTGCTGATTG 1432
479: A P L Y Y G E Q R G G R V F I Y Q K I Q L G F Q M V S E L Q G E T G Y P L G R F G A A I A A L T D I 528
1433: CAGCCCCCCTGTACTATGGGGAGCAGAGAGGAGGCCGGGTGTTTATCTACCAGAAAATACAGCTGGGGTTCCAAATGGTCTCAGAGCTGCAGGGGGAGACCGGCTACCCCCTTGGACGATTTGGAGCCGCCATCGCTGCCCTGACAGACA 1582
529: N G D E L T D V A V G A P L E E Q G A V Y I F N G Q Q G G L S P R P S Q R I E G T Q M F S G I Q W F 578
1583: TCAATGGGGATGAGCTGACGGACGTGGCTGTGGGAGCCCCTCTGGAGGAGCAGGGGGCTGTGTATATCTTCAATGGGCAGCAAGGGGGGCTGAGCCCCCGGCCCAGTCAGCGGATAGAAGGGACCCAGATGTTCTCAGGAATTCAATGGT 1732
579: G R S I H G V K D L G G D G L A D V A V G A E G Q V I V L S S R P V V D I I T S V S F S P A E I P V 628
1733: TTGGACGCTCCATCCACGGGGTGAAGGACCTTGGCGGGGATGGCCTGGCAGATGTGGCTGTGGGGGCTGAGGGCCAGGTGATTGTGCTCAGCTCCCGGCCTGTGGTAGACATCATCACAAGCGTGTCCTTCTCCCCGGCCGAGATCCCAG 1882
629: R E V E C S Y S T S N Q E K E G V N I T V C F Q V K S L I S T F Q G H L V A N L T Y T L Q L D G H R 678
1883: TACGTGAAGTCGAGTGCTCCTATTCCACCAGCAACCAGGAGAAGGAAGGCGTTAACATCACAGTCTGTTTCCAGGTCAAGTCTCTCATCTCCACCTTCCAAGGGCACCTGGTTGCCAACCTCACTTACACTCTGCAGCTGGACGGCCATC 2032
679: T R S R G L F P G G K H E L N G N T A V T S V K S C F M F W F H F P I C I Q D L I S P I N V S L S Y 728
2033: GGACCCGAAGCCGAGGGTTGTTCCCAGGAGGGAAACACGAACTCAACGGGAACACAGCTGTCACCTCTGTCAAGTCCTGCTTTATGTTCTGGTTCCACTTCCCGATATGCATTCAAGATCTCATCTCTCCCATCAACGTCTCCCTAAGTT 2182
729: S L W E E E G T P R D P R A Q G R D I P P I L K P S P H L E T K E I P F E K N C G E D K T C E A D L 778
2183: ATTCTCTCTGGGAGGAAGAAGGGACACCGAGGGACCCAAGGGCGCAGGGCAGGGACATCCCGCCCATCCTGAAACCCTCACCACACTTGGAGACCAAGGAGATTCCTTTTGAGAAGAACTGCGGAGAGGACAAGACTTGTGAGGCAGACC 2332
779: K L A F S D M R S K I L H L T P S A S L S V R L T L R N T A E D A Y W V Q V T L S F P Q G L S F R K 828
2333: TGAAGCTGGCCTTCTCCGACATGAGATCCAAAATCCTGCATCTGACCCCCTCCGCCAGCCTCTCTGTGAGGCTGACACTGAGGAACACAGCAGAAGATGCTTACTGGGTCCAGGTCACCCTGAGCTTCCCCCAGGGACTCTCATTCCGCA 2482
829: V E A L K P H S H V P V G C E E L P E E A I L Q S R A L S C N V S S P I F G A D S M V D I Q V M F N 878
2483: AAGTGGAGGCGCTCAAGCCCCACAGCCATGTACCTGTGGGCTGTGAGGAGCTTCCTGAGGAGGCCATACTGCAGAGCAGGGCCCTCTCCTGCAACGTGAGCTCTCCCATCTTCGGAGCAGACAGCATGGTTGATATCCAGGTGATGTTTA 2632
879: T L Q K G S W G D L I K L H A N V S C D N E N S S L L E D N S A T A S I P V M Y P I N I L T K D Q E 928
2633: ATACGCTGCAGAAAGGCTCCTGGGGGGATTTGATCAAGCTGCACGCCAATGTGAGCTGCGACAATGAGAACTCAAGCCTCCTGGAGGACAACTCGGCCACCGCCAGCATCCCTGTCATGTACCCCATCAACATCCTCACCAAGGACCAGG 2782
929: N S T L Y I N F T P K S P K I H H V K H I Y Q V R I Q P S N Y D N V P P L E A L V R V P Q V H S E E 978
2783: AAAACTCCACACTGTATATCAACTTCACCCCCAAGAGTCCCAAGATCCACCATGTCAAGCACATCTACCAGGTGAGGATCCAGCCTTCTAACTATGACAACGTGCCCCCACTGGAGGCCTTGGTTAGGGTACCACAGGTGCACAGCGAGG 2932
979: L I T H R W S I Q M E P P V N C S S R N L E S P S D V A E P G S F G T E F R C P I D F R Q E I L V Q 1028
2933: AGCTCATCACCCACAGGTGGAGCATACAGATGGAGCCTCCAGTCAACTGCAGCTCCAGAAATCTGGAGAGTCCATCTGATGTGGCTGAGCCTGGCTCGTTTGGAACTGAGTTCCGCTGCCCAATCGACTTCAGGCAGGAGATCCTTGTCC 3082
1029: V N G T V E L R G T I K A S S M L S L S S S L S I S F N S S K H F H L Y G S N A S M A Q V V M K V D 1078
3083: AAGTGAACGGGACGGTGGAGTTGAGGGGGACGATCAAGGCCTCCTCCATGTTGAGCCTTTCTAGCTCCCTCTCCATCTCCTTCAACAGCAGCAAGCACTTTCACCTCTATGGCAGCAACGCCTCCATGGCCCAGGTCGTCATGAAGGTTG 3232
1079: L V Y E K K M L Y L Y V L S G I G G L L L L L L I F I A L Y K V G F F K R N L K E K M E A N V D A S 1128
3233: ACCTTGTATATGAGAAAAAGATGCTCTATCTCTACGTGCTGAGTGGAATCGGGGGGCTGTTGTTGCTGCTCCTGATTTTCATAGCTCTGTACAAGGTTGGTTTCTTCAAACGGAACCTGAAGGAGAAGATGGAGGCAAATGTAGATGCTT 3382
1129: S E I P A E D A G Q P E L E K E F K D P G C L E P L Q K K D E D E S G G D * 1165
3383: CCAGTGAAATCCCTGCAGAAGATGCTGGGCAGCCAGAGTTGGAGAAAGAGTTCAAGGACCCAGGCTGCCTGGAGCCCCTCCAGAAGAAGGATGAGGATGAAAGTGGTGGAGATTGAGGTGC 3503Page 3 of 6
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portion. Of nine potential Asn-glycosylation sites in
caprine CD11a, the ones present at amino acids 185, 667,
723 and 859 are strictly conserved, one is only absent
from murine and rat CD11a (residue 894), without pre-
dictable consequences on a functional point of view.
Interestingly, as in sheep [34] and human [GenBank:
NM_002209 and AY892236], an allelic variant with a tri-
plet insertion resulting in an additional Glu744 in the
extracellular domain was consistently identified, which
suggests an allelic polymorphism that might be biologi-
cally relevant. Studies of genomic sequences will permit to
know if this addition represents two alleles or not.
Finally, one has to note that the lowest between-species
percent identities are observed with the rat CD11a
sequence which has been derived from an annotated
genomic sequence. Cloning and characterisation of rat
CD11a from rat PBMCs would probably give a higher
identity.
Conclusion
This study reports for the first time the isolation and
sequencing of the caprine LFA-1 α subunit (CD11a)
cDNA, and demonstrates that, despite some focal differ-
ences, it shares all the main characteristics of its known
mammalian homologues. Along with the caprine CD18-
encoding cDNA which is now available [17], the sequence
Comparison of the caprine (Ca-), bovine (Bo-), human (Hu-), murine (Mu-) and rat (Ra-) α subunits amino acid sequencesFigure 2
Comparison of the caprine (Ca-), bovine (Bo-), human (Hu-), murine (Mu-) and rat (Ra-) α subunits amino acid 
sequences. The letters in the top row identify the constitutive blocks: putative signal peptide (s), extracellular domain (e), 
transmembrane region (t), cytoplasmic tail (c), I-domain (i), MIDAS motif (m) and divalent cation binding motifs (d). Black, dark 
grey and light grey columns represent identity among 6, 5 and 4 species, respectively. Cysteine residues (#) and potential N-
glycosylation sites (*) are marked at the bottom of the sequences. The important Glu-332 residue (+) and the Gln-743 residue 
which is absent in the smaller allele (=) are identified.
ssssssssssssssssssssssssseeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee
CaCD11a : -----------------------------------------------------------------------------------------M-NSCTIVMRF-LLSGPFVFAPAWSYNLDVRHVQNFSFPLAGRHFGYRVLQVGNRVVVGAPNEGNRMGNLYQCQPETGDCLPVTL-SSSYTSKYLGMTLATDPTSGNLLACDPGLS : 113
# * # # #
BoCD11a : -----------------------------------------------------------------------------------------M-NSCIIVLRL-LLSGPFVFAPAWSYNLDVRHVQNFSFPLAGRHFGYRVLQVGNGVVVGAPSEGNSMGNLYQCQPETGDCLPVTL-SSNYTSKYLGMTLATDPTSDNLLACDPGLS : 113
# * # # * #
OvCD11a : -----------------------------------------------------------------------------------------M-NSYTIVMRF-LLSGPFVFAPAWSYNLDVRHVQSFSFPLAGRHFGYRVLQVGNRVVVGAPNEGNRMGNLYQCQPETGDCLPVTL-SSSYTSKYLGMTLATDPTSGNLLACDPGLS : 113
# # #
HuCD11a : -----------------------------------------------------------------------------------------MKDSCITVMAMALLSGFFFFAPASSYNLDVRGARSFSPPRAGRHFGYRVLQVGNGVIVGAPGEGNSTGSLYQCQSGTGHCLPVTLRGSNYTSKYLGMTLATDPTDGSILACDPGLS : 116
# * # # * #
MuCD11a : -------------------------------------------------------------------------------------------MSFRIAGPRLLLLGLQLFAKAWSYNLDTRPTQSF-LAQAGRHFGYQVLQIEDGVVVGAPGEGDNTGGLYHCRTSSEFCQPVSLHGSNHTSKYLGMTLATDAAKGSLLACDPGLS : 113
# # * #
RaCD11a : MALRICWRQEHQSGHTPPPPPPHPRIPGAVTCSPSCRWQACVLSSLAVQTGSDLNQLGALGQTPLHKAAKVGSLECLSLLVANEVQTDGCNKNGQMAEDLAWSCGLPV--NAWSYNLDTRHAQSF-LTQAGRHFGYQVLQFGDGVVVGAPGEGNSTGSLYHCHPSSGSCQPVHL-GSNHTSKYLGMTMVTDAAKGSLLACDPGLS : 201
# # # # # # * # # * #
eeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeiiiiiimmmmmiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiimiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiimiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
CaCD11a : RTCDQNIYLSGLCYLIHENLRGPVLQGHPGYQECIKGNVDLVFLFDGSMSLQQDEFGKIVDFMKDVMKKLSNSSYQFAAVQFSTDFKTEFTFLDYNRQ-KDPDALLAGVKHMRLLTNTFGAINYVAKEVFRQELGARPDATKVLIIITDGEATDEQNIDAAKDIIRYIIGIGKNFKTKESQEALHQFASKPVEEFVKILDTFEKL : 317
# # # *
BoCD11a : RTCDQNIYLSGLCYLIHENLRGPVLQGHPGYQECIKGNVDLVFLFDGSMSLQQDEFEKIVDFMKDVMKKLSNSSYQFAAVQFSTYFRTEFTFLDYIRQ-KDPDALLAGVKHMRLLTNTFGAINYVAKEVFRPDLGARPDATKVLIIITDGEATDEHNIDAAKDIIRYIIGIGKNFKTKESQEALHQFASKPVEEFVKILDTFEKL : 317
# # # *
OvCD11a : RTCDQNIYLSGLCYLIHENLRGPVLQGYPGYQECIKGNVDLVFLFDGSMSLQQDEFEKIVDFMKDVMKKLSNSSYQFAAVQFSTDFKTEFTFLDYNRQ-KDPDALLAGVKHMRLLTNTFGAINYVAKEVFRQELGARPDATKVLIIITDGEATDEQNIDAAKDIIRYIIGIGKNFKTKESQEALHQFASKPVEEFVKILDTFEKL : 317
# # # *
HuCD11a : RTCDQNTYLSGLCYLFRQNLQGPMLQGRPGFQECIKGNVDLVFLFDGSMSLQPDEFQKILDFMKDVMKKLSNTSYQFAAVQFSTSYKTEFDFSDYVKR-KDPDALLKHVKHMLLLTNTFGAINYVATEVFREELGARPDATKVLIIITDGEATDSGNIDAAKDIIRYIIGIGKHFQTKESQETLHKFASKPASEFVKILDTFEKL : 320
# # # *
MuCD11a : RTCDQNTYLSGLCYLFPQSLEGPMLQNRPAYQECMKGKVDLVFLFDGSQSLDRKDFEKILEFMKDVMRKLSNTSYQFAAVQFSTDCRTEFTFLDYVKQNKNPDVLLGSVQPMFLLTNTFRAINYVVAHVFKEESGARPDATKVLVIITDGEASDKGNISAAHDITRYIIGIGKHFVSVQKQKTLHIFASEPVEEFVKILDTFEKL : 318
# # # * #
RaCD11a : RTCDQNPYLSGLCYLFSQSLGKPILQNRPAYQECMKGNVDLVFLFDGSQSLDKKDFEKIVDFMKDVMRKLSNTSYQFAAVQFSTECKTEFTFLDYIKLNKNPDVLLGNVTPMFLLTNTFRAINYVVTHVFKEESGARPDATKVLVIITDGEASDNGNIDAAQDITRYIIGIGKHFSTTQKQEKLHIFASKPVEEFVKILDTFEKL : 406
# # # * #
iiiiiiieeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeedddddddddeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee
CaCD11a : KDLFTELQKKIYVIEG--------TSKQDLTSFNMELSSSGISADLSEGHGVVGAVGAKDWAGGFLDLKADLQSSTFVGNEQLTVESREGYLGYTVTWLPSRGTMSLLATGAPRYQHVGRVLLFQQPKRGGPWSQIQKIDGIQVGSYFGGELCGVDVDRDGETELLLIAAPLYYGEQRGGRVFIYQKIQLGFQMVSELQGETGYP : 514
+ #
BoCD11a : KDLFTELQKKIYVIEG--------TSKQDLTSFNMELSSSGISADLSEGHGVVGAVGAKDWAGGFLDLKADLKSSTFVGNEPLTVESRAGYLGYTVTWLPSRGTMSLLATGAPRYQHVGRVLLFQQPKRGGPWSQIQEIDGIQIGSYFGGELCGVDVDRDGETELLLIAAPLYYGEQRGGRVFIYQKIQLEFQMVSELQGETGYP : 514
+ #
OvCD11a : KDLFTELQKKIYVIEG--------TSKQDLTSFNMELSSSGISADLSEGHGVVGAVGAKDWAGGFLDLKADLQSSTFVGNEQPTVESREGYLGYTVTWLPSRGMMSLLATGAPRYQHVGRVLLFQQPKRGGPWSQIQKIDGIQVGSYFGGELCGVDVDRDGETELLLIAAPLYYGEQRGGRVFIYQKIQLGFQMVSELQGETGYP : 514
+ #
HuCD11a : KDLFTELQKKIYVIEG--------TSKQDLTSFNMELSSSGISADLSRGHAVVGAVGAKDWAGGFLDLKADLQDDTFIGNEPLTPEVRAGYLGYTVTWLPSRQKTSLLASGAPRYQHMGRVLLFQEPQGGGHWSQVQTIHGTQIGSYFGGELCGVDVDQDGETELLLIGAPLFYGEQRGGRVFIYQRRQLGFEEVSELQGDPGYP : 517
+ #
MuCD11a : KDLFTDLQRRIYAIEG--------TNRQDLTSFNMELSSSGISADLSKGHAVVGAVGAKDWAGGFLDLREDLQGATFVGQEPLTSDVRGGYLGYTVAWMTSRSSRPLLAAGAPRYQHVGQVLLFQAPEAGGRWNQTQKIEGTQIGSYFGGELCSVDLDQDGEAELLLIGAPLFFGEQRGGRVFTYQRRQSLFEMVSELQGDPGYP : 515
+ * #
RaCD11a : KDLFTDLQRKIYAIEGESRTLAAGTSKQDLASFNMELSSSGISADLSKGHAVVGAVGAKDWAGGFLDLHEDLEGATFVGQEPLTSDERGGYLGYTVAWLTSRSSRPLLAAGAPRYQHVGQVLLFQAPEAGGHWNQTQKIEGTQIGSYFGGELCSVDLHQDGETDLLLIGAPLFYGEQRGGRVSVYQRRRSLFEMVSELQGDPGYP : 611
+ * #
eeeeeeeeeeeedddddddddeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeedddddddddeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee
CaCD11a : LGRFGAAIAALTDINGDELTDVAVGAPLEEQGAVYIFNGQQGGLSPRPSQRIEGTQMFSGIQWFGRSIHGVKDLGGDGLADVAVGAEGQVIVLSSR-PVVDIITSVSFSPAEIPVREVECSYSTSNQEKEGVNITVCFQVKSLISTFQGHLVANLTYTLQLDGHRTRSRGLFPGGKHELNGNTAVTSVKSCFMFWFHFP------ : 712
# * # * #
BoCD11a : LGRFGAAIAALTDINGDELTDVAVGAPLEEQGAVYIFNGQQGGLSPRPSQRIEGTQMFSGIQWFGRSIHGVKDLGGDGLADVAVGAEGQVIVLSSR-PVVDIITSVSFSPAEIPVHEVECSYSTSNQKKEGVNLTVCFQVKSLISTFQGHLVANLTYTLQLDGHRTRSRGLFPGGKHKLIGNTAVTPVKSCFVFWFHFP------ : 712
# # * #
OvCD11a : LGRFGAAIAALTDINGDELTDVAVGAPLEDQGAVYIFNGQQGGLSPRPSQRIEGTQMFSGIQWFGRSIHGVKDLGGDGLADVAVGAEGQVIVLSSR-PVVDIITSMSFSPAEIPVREVECSYSTSNQEKEGVNITVCFQVKSLISTFEGHLVANLTYTLQLDGHRTRSRGLFPGGKHELNGNTAVTSVKSCFMFWFHFP------ : 712
# * # * #
HuCD11a : LGRFGEAITALTDINGDGLVDVAVGAPLEEQGAVYIFNGRHGGLSPQPSQRIEGTQVLSGIQWFGRSIHGVKDLEGDGLADVAVGAESQMIVLSSR-PVVDMVTLMSFSPAEIPVHEVECSYSTSNKMKEGVNITICFQIKSLYPQFQGRLVANLTYTLQLDGHRTRRRGLFPGGRHELRRNIAVTTSMSCTDFSFHFP------ : 715
# # * #
MuCD11a : LGRFGAAITALTDINGDRLTDVAVGAPLEEQGAVYIFNGKPGGLSPQPSQRIQGAQVFPGIRWFGRSIHGVKDLGGDRLANVVVGPEGRVVVLSSR-PVVDVVTELSFSPEEIPVHEVECSYSAREEQKHGVKLKACFRIKPLTPQFQGRLLANLSYTLQLDGHRMRSRGLFPDGSHELSGNTSITPDKSCLDFHFHFP------ : 713
# # * * #
RaCD11a : LGRFGAAISALTDINGDGLTDVAVGAPLEEQGAVYIFNGKPGGFSSQSSQRIPGTQVSPGVRWFGRSIHGVKDLGGDRLADVVVGAEGQVIVLRAIIPDCGLLTSTGIV-DEIPVHEVECSYSASQEQKEGVKLKVCFQIRPLTSQFQGRLLANLSYTLQLDGHRTRSRGLFPGGSRELGGNTSVTPDKSCMDFHFHFPVRQPVL : 815
# # * * #
eeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee
CaCD11a : --------ICIQDLISPINVSLSYSLWEEEGTPRDPRA-----------------------------------------------------------------------------------QGRDIPPILKPSPHLETKEIPFEKNCGEDKTCEADLKLAFSDMRSKILHLTPSASLSVRLTLRNTAEDAYWVQVTLSFPQGLSF : 826
# * = # #
BoCD11a : --------ICIQDLISPINVSLSYSLWEEEGTPRDPRA-----------------------------------------------------------------------------------LDRDIPPILKPSPHLETKEIPFEKNCGEDKNCEADLKLAFSDMRSKILRLTPSASLSVRLTLRNTAEDAYWVQVTLSFPQGLSF : 826
# * # #
OvCD11a : --------ICIQDLISPINVSLSYSLWEEEGTPRDPRA-----------------------------------------------------------------------------------QGRDIQPILKPSPHLETKEIPFEKNCGEDKTCEADLKLAFSDMRSKILHLTPSASLSVRLTLRNTAEDAYWVQVTLSFPQGLSF : 826
# * = # #
HuCD11a : --------VCVQDLISPINVSLNFSLWEEEGTPRDQRA-----------------------------------------------------------------------------------QGKDIPPILRPSLHSETWEIPFEKNCGEDKKCEANLRVSFSPARSRALRLTAFASLSVELSLSNLEEDAYWVQLDLHFPPGLSF : 829
# * * = # #
MuCD11a : --------ICIQDLISPINVSLNFSLLEEEGTPRDQK-------------------------------------------------------------------------------------GRAMQPILRPSIHTVTKEIPFEKNCGEDKKCEANLTLS-SPARSGPLRLMSSASLAVEWTLSNSGEDAYWVRLDLDFPRGLSF : 824
# * * # # *
RaCD11a : EFREGLTAICIQDLISPINVSLNFSLLEEEGSPRDQKGLLMGVFSVGGKGPTKTRLPYSAFCDGNKYANSQVIKKKGSSGLTSVVIVYDHQFCRFGPLTGAYYAQDLLTQLSTLSSLLRPQQGRDMQPILRPSIHAVTKEIPFEKNCGEDKKCEADLALS-PPARSGVLRLMSSASLAVEWTLRNLGEDAYWVRLDLDFPRGLSF : 1019
# * * # # = # #
eeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee
CaCD11a : RKVEALKPHSHVPVGCEELPEEAILQSRALSCNVSSPIFGADSMVDIQVMFNTLQKGSWGDLIKLHANVSCDNENSSLLEDNSATASIPVMYPINILTKDQENSTLYINFTPKSPKIHHVKHIYQVRIQPSNYD-NVPPLEALVRVPQVHSEELITHRWSIQMEPPVNCSSRNLESPSDVAEPGSFGTEFRCPIDFRQEILVQVN : 1030
# #* * # *# # *
BoCD11a : RKVEILKPHSHVPVGCEELPEEAVVHSRALSCNVSSPIFGEDSMVDIQVMFNTLQKGSWGDFIELQANVSCNNEDSSLLEDNSATTSIPVMYPINVLTKDQENSTLYISFTPKSPKIHHVKHIYQVRIQPSNYD-NMPPLEALVRVPRVHSEGLITHKWSIQMEPPVNCSPRNLESPSDEAESCSFGTEFRCPIDFRQEILVQVN : 1030
# #* * # # # #
OvCD11a : RKVEALKPHSHVPVGCEELPEEAILQSRALSCNVSSPIFGADSMVDIQVMFNTLQKGSWGDLIELHANVSCDNENSSLLEDNSATASIPVMYPINILTKDQENSTLYISFTPKSPKIHHVKHIYQVRIQPSNYD-NVPPLEALVRVPRVHSEGLITHRWSIQMEPPVNCSPRNLESPSDVAEPCSFGTEFRCPIDFRQEILVQVN : 1030
# #* * # # # # *
HuCD11a : RKVEMLKPHSQIPVSCEELPEESRLLSRALSCNVSSPIFKAGHSVALQMMFNTLVNSSWGDSVELHANVTCNNEDSDLLEDNSATTIIPILYPINILIQDQEDSTLYVSFTPKGPKIHQVKHMYQVRIQPSIHDHNIPTLEAVVGVPQPPSEGPITHQWSVQMEPPVPCHYEDLERLPDAAEPCLPGALFRCPVVFRQEILVQVI : 1034
# #* * # # # #
MuCD11a : RKVEMLQPHSRMPVSCEELTEGSSLLTKTLKCNVSSPIFKAGQEVSLQVMFNTLLNSSWEDFVELNGTVHCENENSSLQEDNSAATHIPVLYPVNILTKEQENSTLYISFTPKGPKTQQVQHVYQVRIQPSAYDHNMPTLEALVGVPRPHSEDLITYTWSVQTDPLVTCHSEDLKRPSSEAEPCLPGVQFRCPIVFRWEILIQVT : 1029
# #* * * # * # # #
RaCD11a : RKVEMLQPHSQIPVSCEELTEESSLLTKTLKCNVSSPIFKAGKQMTLQVMFNTLLNSSWGDFVELNGTVHCENENSSLGKDNSATTRIPVLYPVNILTEDQENSTLYISFTPKGPKTQQVQHIYKVRIQPSAYDHNMPALEALVEVPQPHSEGPIAHTWTVHT------------------QPCLPGVQFRCPIVFRQETFIRVA : 1206
# #* * # # #
eeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeeettttttttttttttttttttttttccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
CaCD11a : GTVELRGTIKASSMLSLSSSLSISFNSSKHFHLYGSNASMAQV-----------------------------------------------VMKVDLVYEKKMLYLYVLSGIGGLLLLLLIFIALYKVGFFKRNLKEKMEANVDASSEIPAEDAGQPEL-EKEFKDPGCLEPLQKKD-EDESGGD- : 1165
#
BoCD11a : GMVELRGTIKASSMLSLCSSLAISFNSSKHFHLYGRNASMAQV-----------------------------------------------VMKVDLVYEKEMLYLYVLSGIGGLLLLFLIFIALYKVGFFKRNLKEKMEANVDASSEIPGEDAGQPEL-EKECKDPGCLEPLQKTD-EDGSGGD- : 1165
# # #
OvCD11a : GTVELRGTIKASSMLSLCSSLSISFNSSKHFHLYGSNASMAQV-----------------------------------------------VMKVDLVYEKKMLYLYVLSGIGGLLLLLLIFIALYKVGFFKRNLKEKMEANVDASSEIPGEDAGQPEL-EKEFKDPGCLEPLQKED-EDGSGGD- : 1165
# #
HuCD11a : GTLELVGEIEASSMFSLCSSLSISFNSSKHFHLYGSNASLAQV-----------------------------------------------VMKVDVVYEKQMLYLYVLSGIGGLLLLLLIFIVLYKVGFFKRNLKEKMEAGRGVPNGIPAEDSEQLAS-GQEAGDPGCLKPLHEKDSESGGGKD- : 1170
# #
MuCD11a : GTVELSKEIKASSTLSLCSSLSVSFNSSKHFHLYGSKASEAQV-----------------------------------------------LVKVDLIHEKEMLHVYVLSGIGGLVLLFLIFLALYKVGFFKRNLKEKMEADGGVPNGSPPEDTDPLAVPGEETKDMGCLEPLRESD------KD- : 1160
# #
RaCD11a : GTVELSEKIKASSTLSLCSSLSVSFNSSKHFHLYGSKASKAQVCAPQKPRPGSRELGGDPGYSSYRGATQKESLAQSDLNLIQIPVKQEVLMKVDMIYEKEMLHLYVLSGIGGLLLLSLIFLALYKVGFFKRKLKEKMEADGGVPNGSPGEDADPLAVPGEETKDMGCLEPLRESDKD------- : 1384
# # #Page 4 of 6
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caprine LFA-1 in vitro as a tool to examine the specificities
of inflammation in the caprine species.
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